Skip to content
healthcare.dev

Rabeprazole Sodium

NDC 76420-107, Rabeprazole Sodium, tablet, delayed release, from Asclemed USA, Inc..

Product NDC
76420-107
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205761
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-107 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RABEPRAZOLE SODIUM20 mg/1

Pharmacologic classes

Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
76420-107-307642001073030 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-107-30)
76420-107-607642001076060 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-107-60)
76420-107-907642001079090 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-107-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/12eaf996-db61-41d6-82e1-fa6196435603

Use it

Look up 76420-107 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-107 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-107. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.